Kymera Investor Day Presentation Deck slide image

Kymera Investor Day Presentation Deck

KT-253, a First-in-Class MDM2 Degrader in Development for Solid and Liquid Tumors Juliet Williams, Ph.D., SVP, Head of Biology, Kymera KYMERA KYMERA R&D DAY - December 16th, 2021 5 KYMERA EST. 2016
View entire presentation